However, it remains controversial whether SIRT3 acts as a tumor promoter or a tumor suppressor in tumorigenesis, because there were conflicting results in colon cancer [20], liver cancer [21], and breast cancer [9]. This evidence concerns the gene SIRT3 and breast carcinoma.